Mixed connective tissue disease (MCTD) is an overlap autoimmune syndrome combining features of lupus, scleroderma, polymyositis, and rheumatoid arthritis, defined by anti-U1 RNP antibodies. MCTD is driven by B-cell dysregulation, TGF-beta fibrosis, Raynaud's vasospasm, and multi-organ inflammation. Sea moss fucoidan modulates B-cell activation and TGF-beta fibrotic pathways; selenium supports hepatic and systemic GPx antioxidant protection; omega-3 precursors modulate vascular inflammation in Raynaud's; zinc supports Treg function. DMARDs (hydroxychloroquine, methotrexate) and vasodilators are standard; sea moss provides multi-target nutritional support alongside rheumatologist care.

Shop All